Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

BACKGROUND: The expression of HER2, estrogen (ER) and progesterone (PR) receptor can change during the course of the disease in breast cancer (BC). Therefore, reassessment of these markers at the time of disease progression might help to optimize treatment decisions. In this context, characterizatio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Aktas, Bahriye, Kasimir-Bauer, Sabine, Müller, Volkmar, Janni, Wolfgang, Fehm, Tanja, Wallwiener, Diethelm, Pantel, Klaus, Tewes, Mitra
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4960681/
https://ncbi.nlm.nih.gov/pubmed/27456970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2587-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi